Cover Image
市場調查報告書

基因編輯、基因工程的全球市場的預測 ∼2022年:CRISPR、TALEN、ZFN,細胞株工程、動物基因工程學、植物基因工程學

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022

出版商 MarketsandMarkets 商品編碼 329686
出版日期 內容資訊 英文 166 Pages
訂單完成後即時交付
價格
Back to Top
基因編輯、基因工程的全球市場的預測 ∼2022年:CRISPR、TALEN、ZFN,細胞株工程、動物基因工程學、植物基因工程學 Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology & Pharmaceutical Companies, CROs) - Global Forecast 2022
出版日期: 2017年11月20日 內容資訊: 英文 166 Pages
簡介

全球基因編輯、基因工程的市場在預測期間內預計以14.5%的年複合成長率發展,2022年成長到62億8000萬美元的規模。國家的資金合作的擴大和計劃數的增加,感染疾病及癌症的高盛行率,技術的進步,GM作物的製造,用途的擴大等要素促進該市場的成長。

本報告提供全球基因編輯及基因工程的市場調查,市場及技術概要,市場成長的各種影響因素及市場機會分析,各技術、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 歐洲市場:各用途
  • 各終端用戶市場
  • 各地區、國家市場

第5章 市場概要

  • 簡介
  • 宏觀指標
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 市場分析、預測:各技術

  • 簡介
  • CRISPR
  • TALEN
  • ZFN
  • 反義
  • 其他

第7章 市場分析、預測:各用途

  • 簡介
  • 細胞株工程
  • 基因工程學
    • 動物基因工程學
    • 植物基因工程學
  • 其他

第8章 市場分析、預測:各終端用戶

  • 簡介
  • 生物科技&醫藥品企業
  • 學術、政府研究機關
  • CRO

第9章 市場分析、預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第10章 競爭環境

  • 主要企業的主要發展
  • 市場佔有率分析
  • 競爭模式
    • 協定、聯盟、合作
    • 新產品與服務的投入
    • 收購
    • 擴張

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC
  • MERCK
  • HORIZON DISCOVERY GROUP
  • GENSCRIPT
  • SANGAMO BIOSCIENCES
  • INTEGRATED DNA TECHNOLOGIES
  • LONZA
  • NEW ENGLAND BIOLABS
  • ORIGENE TECHNOLOGIES
  • TRANSPOSAGEN BIOPHARMACEUTICALS
  • EDITAS MEDICINE
  • CRISPR THERAPEUTICS

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 3380

"The genome editing/genome engineering market is projected to grow at a CAGR of 14.5%."

The global genome editing market is expected to grow at a CAGR of 14.5% to reach to USD 6.28 billion by 2022. The key factors propelling the growth of this market are rising government funding and growth in the number of genomics projects, high prevalence of infectious diseases and cancer, technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.

"The CRISPR segment is expected to grow at the highest rate during the forecast period."

By technology, the market is segmented into CRISPR, TALEN, ZFN, antisense, and other technologies (PiggyBac, Flp-In, Adenine Base Editor (ADE), and Jump-In). The CRISPR segment is estimated to grow at the highest CAGR during the forecast period. The ease of use associated with the CRISPR technology is a significant advantage over ZFN and TALEN, especially in generating a large set of vectors to target numerous sites or even genome-wide libraries. Another potential advantage of CRISPR is its ability to multiplex, that is, to use multiple guide RNAs in parallel to target multiple sites simultaneously in the same cell. This makes it easier to mutate multiple genes at once or engineer precise deletions in a genomic region.

"The pharmaceutical and biotechnology companies segment is expected to be the fastest growing end-user segment."

On the basis of end user, the market is classified into pharmaceutical and biotechnology companies, academic & government research institutes, and contract research organizations. The pharmaceutical and biotechnology companies segment is estimated to grow at the fastest rate during the forecast period. The increasing prevalence of infectious diseases and cancer are driving research activities worldwide; this is expected to drive the demand for genome editing in biotechnology & pharmaceutical companies.

"North America to dominate the genome editing/genome engineering market and is projected to grow at the highest CAGR during the forecast period."

The North American region is expected to hold the largest share of the global market in 2017. This regional segment is also expected to grow at the highest CAGR during the forecast period. The large share and high growth rate of this region can be attributed to factors such as the development of gene therapy in the US, increasing use of genetically modified crops, rising prevalence of infectious diseases and cancer, and rising availability of research grants and funding.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1: 56%, Tier 2: 35%, and Tier 3: 9%
  • By Designation - C-level: 27%, Director Level: 15%, Others: 58%
  • By Region - North America: 37%, Europe: 23%, Asia Pacific: 25%, RoW: 15%

Thermo Fisher Scientific (US), Merck KGaA (Germany), and Horizon Discovery Group (UK) are some of the major players operating in the market.

Research Coverage:

The report analyzes the market and aims at estimating the market size and the future growth potential of this market based on various segments such as technology, application, end user, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global genome editing/genome engineering market
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global genome editing/genome engineering market
  • Market Development: Comprehensive information about the lucrative emerging markets by technology, application, end user, and region
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global genome editing/genome engineering market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GENOME EDITING: MARKET OVERVIEW
  • 4.2. EUROPE: GENOME EDITING MARKET, BY APPLICATION
  • 4.3. GENOME EDITING MARKET, BY END USER
  • 4.4. GENOME EDITING MARKET, BY COUNTRY/REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising government funding and growth in the number of genomics projects
      • 5.2.1.2. Growing application areas of genomics
      • 5.2.1.3. High prevalence of infectious diseases and cancer
      • 5.2.1.4. Technological advancements
      • 5.2.1.5. Increasing production of genetically modified crops
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Dearth of trained professionals
      • 5.2.2.2. Adverse public perception of genetic research
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Use of genome editing in specialized/personalized medicine
      • 5.2.3.2. Emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. High cost of genomics equipment
      • 5.2.4.2. Off-target effect of CRISPR
      • 5.2.4.3. Secure storage of large volumes of sequenced data

6. GENOME EDITING MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. CRISPR
  • 6.3. TALEN
  • 6.4. ZFN
  • 6.5. ANTISENSE
  • 6.6. OTHER TECHNOLOGIES

7. GENOME EDITING MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CELL LINE ENGINEERING
  • 7.3. GENETIC ENGINEERING
    • 7.3.1. ANIMAL GENETIC ENGINEERING
    • 7.3.2. PLANT GENETIC ENGINEERING
  • 7.4. OTHER APPLICATIONS

8. GENOME EDITING MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
  • 8.3. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
  • 8.4. CONTRACT RESEARCH ORGANIZATIONS

9. GENOME EDITING MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
      • 9.2.1.1. Research grants and funding by government institutes
      • 9.2.1.2. Increasing use of GM crops
      • 9.2.1.3. Prevalence of Alzheimer's disease and other dementias in the US
      • 9.2.1.4. Genome editing conferences in the US
      • 9.2.1.5. Increasing prevalence of cancer
      • 9.2.1.6. Strategic developments in the US market
    • 9.2.2. CANADA
      • 9.2.2.1. Availability of research funding in Canada
      • 9.2.2.2. Rising incidence of cancer
      • 9.2.2.3. GAPP to intensify genomic R&D
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Presence of a large number of academic institutes
      • 9.3.1.2. Availability of funding for life science research
      • 9.3.1.3. Conferences/Meetings/Symposiums/Workshops in Germany
    • 9.3.2. UK
      • 9.3.2.1. Increasing funds and grants by government bodies
      • 9.3.2.2. 100,000 Genomes Project in the UK
    • 9.3.3. FRANCE
      • 9.3.3.1. Increasing government investments in genomics
      • 9.3.3.2. Introduction of noninvasive prenatal testing in France
    • 9.3.4. ROE
      • 9.3.4.1. Spain's focus on research
      • 9.3.4.2. Growth in the Italian biotech and pharma sectors
      • 9.3.4.3. Growing research investments in Sweden & Denmark
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
      • 9.4.1.1. Government initiatives to support healthcare research in China
      • 9.4.1.2. Efforts of BGI to boost the genomics market in China
      • 9.4.1.3. High intensity of R&D activities in China
    • 9.4.2. JAPAN
      • 9.4.2.1. Increasing government focus on cancer research
      • 9.4.2.2. Conferences and symposiums on genetic engineering in Japan
      • 9.4.2.3. Focus on cancer research and treatment
    • 9.4.3. INDIA
      • 9.4.3.1. Emergence of local players in India backed by government funding
      • 9.4.3.2. Increasing support for biotech start-ups
      • 9.4.3.3. Growth of the pharmaceutical industry in India
    • 9.4.4. ROAPAC
      • 9.4.4.1. Alliances and partnerships in the Australian market
      • 9.4.4.2. Genome Asia 100K initiative
      • 9.4.4.3. Crop research initiatives in Asia
  • 9.5. ROW
    • 9.5.1. LATIN AMERICA
      • 9.5.1.1. Alliances, availability of government funding in Brazil
      • 9.5.1.2. Conferences & workshops in Brazil (2016-2017)
    • 9.5.2. MIDDLE EAST AND AFRICA
      • 9.5.2.1. Genetic testing and genomic analysis in the Middle East
      • 9.5.2.2. Rising prevalence of HIV and cancer in Africa

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY DEVELOPMENTS BY LEADING PLAYERS IN THE GENOME EDITING MARKET

(2014-2017) 117

  • 10.2. MARKET SHARE ANALYSIS
    • 10.2.1. THERMO FISHER SCIENTIFIC
    • 10.2.2. MERCK
    • 10.2.3. HORIZON DISCOVERY GROUP
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
    • 10.3.2. PRODUCT & SERVICE LAUNCHES, BY COMPANY
    • 10.3.3. ACQUISITIONS
    • 10.3.4. EXPANSIONS

11. COMPANY PROFILES (BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

  • 11.1. THERMO FISHER SCIENTIFIC
  • 11.2. MERCK
  • 11.3. HORIZON DISCOVERY GROUP
  • 11.4. GENSCRIPT
  • 11.5. SANGAMO BIOSCIENCES
  • 11.6. INTEGRATED DNA TECHNOLOGIES
  • 11.7. LONZA
  • 11.8. NEW ENGLAND BIOLABS
  • 11.9. ORIGENE TECHNOLOGIES
  • 11.10. TRANSPOSAGEN BIOPHARMACEUTICALS
  • 11.11. EDITAS MEDICINE
  • 11.12. CRISPR THERAPEUTICS

*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. RELATED REPORTS
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 2: CRISPR-BASED GENOME EDITING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 3: TALEN-BASED GENOME EDITING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 4: ZFN-BASED GENOME EDITING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 5: ANTISENSE-BASED GENOME EDITING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 6: GENOME EDITING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 7: GLOBAL GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 8: GENOME EDITING MARKET FOR CELL LINE ENGINEERING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 10: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: GENOME EDITING MARKET FOR ANIMAL GENETIC ENGINEERING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 12: GENOME EDITING MARKET FOR PLANT GENETIC ENGINEERING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: GENOME EDITING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: GLOBAL GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 15: GENOME EDITING MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: GENOME EDITING MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: GENOME EDITING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: GENOME EDITING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: GENOME EDITING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: GENOME EDITING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: NORTH AMERICA: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 25: US: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 26: US: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 27: US: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 28: US: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 29: INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2014
  • TABLE 30: CANADA: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 31: CANADA: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 34: CONFERENCE, MEETING, COURSE AND WORKSHOP IN EUROPE (2014-2018)
  • TABLE 35: EUROPE: GENOME EDITING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 40: CONFERENCES, MEETINGS, SYMPOSIUMS, WORKSHOPS IN GERMANY (2014-2018)
  • TABLE 41: GERMANY: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 42: GERMANY: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 43: GERMANY: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: GERMANY: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: UK: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 46: UK: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 47: UK: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 48: UK: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: FRANCE: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 50: FRANCE: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 51: FRANCE: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 52: FRANCE: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: ROE: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 54: ROE: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 55: ROE: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: FRANCE: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: GENOME EDITING MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 58: ASIA PACIFIC: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA PACIFIC: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 62: CHINA: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: CHINA: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 64: CHINA: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: CHINA: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 66: CONFERENCES, SYMPOSIA, & WORKSHOPS IN JAPAN, 2016-2018
  • TABLE 67: JAPAN: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 68: JAPAN: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 70: JAPAN: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: INDIA: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 72: INDIA: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 73: INDIA: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: EUROPE: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 75: ROAPAC: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 76: ROAPAC: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 77: ROAPAC: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 78: ROAPAC: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: ROW: GENOME EDITING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 80: ROW: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: ROW: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 82: ROW: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 83: ROW: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 84: LATAM: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 85: LATAM: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 86: LATAM: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 87: LATAM: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 88: HIV INFECTIONS AND AIDS-RELATED DEATHS IN THE MIDDLE EAST AND AFRICA, 2014
  • TABLE 89: MEA: GENOME EDITING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 90: MEA: GENOME EDITING MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 91: MEA: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: MEA: GENOME EDITING MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 93: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, BY COMPANY (2015-2017)
  • TABLE 94: PRODUCT & SERVICE LAUNCHES, BY COMPANY (2015-2017)
  • TABLE 95: ACQUISITIONS, BY COMPANY (2015-2017)
  • TABLE 96: EXPANSIONS, BY COMPANY (2015-2017)

LIST OF FIGURES

  • FIGURE 1: GLOBAL GENOME EDITING MARKET SEGMENTATION
  • FIGURE 2: GLOBAL GENOME EDITING MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: BOTTOM-UP APPROACH
  • FIGURE 6: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY (2017-2022)
  • FIGURE 9: GLOBAL GENOME EDITING MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GLOBAL GENOME EDITING MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE GENOME EDITING MARKET
  • FIGURE 12: RISING GOVERNMENT FUNDING AND HIGH PREVALENCE OF INFECTIOUS DISEASES & CANCER-KEY GROWTH DRIVERS OF THE GENOME EDITING MARKET
  • FIGURE 13: CELL LINE ENGINEERING SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 14: BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE GENOME EDITING MARKET IN 2022
  • FIGURE 15: NORTH AMERICA TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 16: GENOME EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD MILLION)
  • FIGURE 18: GLOBAL GENOME EDITING MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 19: GENOME EDITING MARKET FOR GENETIC ENGINEERING, BY TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 20: GENOME EDITING MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 21: GENOME EDITING MARKET, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 22: NORTH AMERICA: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 23: NORTH AMARICA: NUMBER OF NEW CANCER CASES, BY COUNTRY
  • FIGURE 24: PREVALENCE OF ALZHEIMER'S DISEASE IN THE US, BY AGE (2016)
  • FIGURE 25: EUROPE: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 26: EUROPE: NUMBER OF NEW CANCER CASES, BY COUNTRY
  • FIGURE 27: ASIA PACIFIC: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 28: APAC: NUMBER OF NEW CANCER CASES, BY TYPE
  • FIGURE 29: ROW: GENOME EDITING MARKET SNAPSHOT
  • FIGURE 30: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
  • FIGURE 31: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • FIGURE 32: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, BY COMPANY (2014-2017)
  • FIGURE 33: PRODUCT & SERVICE LAUNCHES, BY COMPANY (2014-2017)
  • FIGURE 34: ACQUISITIONS, BY COMPANY (2014-2017)
  • FIGURE 35: EXPANSIONS, BY COMPANY (2014-2017)
  • FIGURE 36: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 37: MERCK: COMPANY SNAPSHOT
  • FIGURE 38: HORIZON DISCOVERY: COMPANY SNAPSHOT
  • FIGURE 39: GENSCRIPT : COMPANY SNAPSHOT
  • FIGURE 40: SANGAMO BIOSCIENCES: COMPANY SNAPSHOT
  • FIGURE 41: LONZA: COMPANY SNAPSHOT
  • FIGURE 42: EDITAS MEDICINE: COMPANY SNAPSHOT
Back to Top